X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8077) 8077
Publication (742) 742
Book Chapter (62) 62
Book Review (48) 48
Dissertation (10) 10
Book / eBook (7) 7
Conference Proceeding (3) 3
Government Document (3) 3
Web Resource (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6598) 6598
female (6045) 6045
index medicus (3782) 3782
middle aged (3615) 3615
oncology (3272) 3272
aged (3015) 3015
ovarian neoplasms - pathology (2752) 2752
adult (2610) 2610
cancer (2413) 2413
ovarian cancer (2153) 2153
cystadenocarcinoma, serous - pathology (1960) 1960
obstetrics & gynecology (1950) 1950
pathology (1826) 1826
prognosis (1814) 1814
carcinoma (1793) 1793
neoplasm staging (1554) 1554
immunohistochemistry (1453) 1453
aged, 80 and over (1449) 1449
ovarian neoplasms - genetics (1300) 1300
tumors (1219) 1219
ovarian neoplasms - metabolism (1063) 1063
retrospective studies (1010) 1010
chemotherapy (991) 991
surgery (967) 967
expression (953) 953
cystadenocarcinoma, serous - genetics (924) 924
survival (915) 915
serous carcinoma (874) 874
cystadenocarcinoma, serous - metabolism (871) 871
male (825) 825
endometrial neoplasms - pathology (817) 817
diagnosis (772) 772
adenocarcinoma (771) 771
survival rate (697) 697
analysis (684) 684
ovarian neoplasms - drug therapy (678) 678
endometrial cancer (674) 674
mutation (652) 652
ovarian neoplasms - mortality (632) 632
diagnosis, differential (624) 624
research (605) 605
follow-up studies (595) 595
women (590) 590
neoplasm grading (586) 586
metastasis (581) 581
treatment outcome (557) 557
cystadenocarcinoma, serous - drug therapy (540) 540
ovarian neoplasms - surgery (535) 535
adenocarcinoma, clear cell - pathology (531) 531
carcinoma, endometrioid - pathology (528) 528
obstetrics and gynecology (527) 527
cystadenocarcinoma, serous - surgery (516) 516
biomarkers, tumor - metabolism (509) 509
cystadenocarcinoma, serous - mortality (504) 504
hematology, oncology and palliative medicine (497) 497
breast-cancer (483) 483
ovary (483) 483
biomarkers, tumor - analysis (480) 480
risk factors (480) 480
ovarian carcinoma (472) 472
ovarian neoplasms - diagnosis (472) 472
article (471) 471
care and treatment (464) 464
gene expression regulation, neoplastic (461) 461
health aspects (446) 446
p53 (444) 444
genetic aspects (443) 443
young adult (440) 440
neoplasms, cystic, mucinous, and serous - pathology (435) 435
cell biology (431) 431
neoplasm invasiveness (430) 430
gene expression (426) 426
animals (422) 422
disease-free survival (419) 419
medicine & public health (412) 412
adenocarcinoma, mucinous - pathology (410) 410
adolescent (401) 401
antineoplastic combined chemotherapy protocols - therapeutic use (400) 400
cell line, tumor (386) 386
survival analysis (385) 385
papillary serous carcinoma (383) 383
endocrine system diseases (378) 378
mutations (371) 371
carcinoma, ovarian epithelial (366) 366
cells (365) 365
fallopian-tube (362) 362
cystadenocarcinoma, serous - diagnosis (360) 360
neoplasms (348) 348
pancreatic neoplasms - pathology (342) 342
cystadenoma, serous - pathology (338) 338
management (332) 332
adenocarcinoma - pathology (331) 331
neoplasms, glandular and epithelial - pathology (324) 324
development and progression (323) 323
peritoneal neoplasms - pathology (313) 313
proteins (308) 308
biomarkers, tumor - genetics (305) 305
risk (305) 305
gynecologic-oncology-group (301) 301
ovarian neoplasms - therapy (301) 301
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7585) 7585
Chinese (175) 175
French (90) 90
German (86) 86
Japanese (68) 68
Korean (41) 41
Spanish (38) 38
Polish (14) 14
Russian (14) 14
Czech (6) 6
Bulgarian (5) 5
Hungarian (4) 4
Romanian (4) 4
Turkish (4) 4
Italian (3) 3
Danish (2) 2
Dutch (1) 1
Hebrew (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 03/2015, Volume 39, Issue 3, pp. 287 - 293
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 07/2017, Volume 123, Issue 13, pp. 2404 - 2412
Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human... 
human papillomavirus (HPV) | developing world | Cervix Cancer Research Network (CCRN) | Gynecological Cancer InterGroup (GCIG) | brachytherapy | cervical cancer | chemotherapy | activism | vaccination | GYNECOLOGIC-ONCOLOGY-GROUP | FOLLOW-UP | RANDOMIZED-TRIAL | HUMAN-PAPILLOMAVIRUS | INTRAEPITHELIAL NEOPLASIA | RADIATION-THERAPY | UTERINE CERVIX | 9-VALENT HPV VACCINE | ONCOLOGY | DOSE-RATE BRACHYTHERAPY | LOCALLY ADVANCED-CARCINOMA | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Carcinoma, Neuroendocrine - therapy | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Chemoradiotherapy, Adjuvant | Fertility Preservation | Early Medical Intervention | Female | Brachytherapy | Radiotherapy, Adjuvant | Uterine Cervical Neoplasms - therapy | Carcinoma, Adenosquamous - pathology | Neoplasms, Cystic, Mucinous, and Serous - pathology | Papillomavirus Vaccines - therapeutic use | Global Health | Early Detection of Cancer | Uterine Cervical Neoplasms - prevention & control | Carcinoma, Squamous Cell - therapy | Carcinoma, Squamous Cell - prevention & control | Hysterectomy | Carcinoma, Small Cell - therapy | Neoplasms, Cystic, Mucinous, and Serous - therapy | Carcinoma, Adenosquamous - therapy | Cisplatin - therapeutic use | Carcinoma, Neuroendocrine - pathology | Papillomavirus Infections - prevention & control | Adenocarcinoma, Clear Cell - therapy | Uterine Cervical Neoplasms - virology | Adenocarcinoma, Clear Cell - pathology | Carcinoma, Small Cell - pathology | Prevention | Women | Usage | Chemotherapy | Radioisotope brachytherapy | Diagnosis | Radiotherapy | Health aspects | Cervical cancer | Cancer | Vaccination | Infections | Malignancy | Biology | Radiation therapy | Cervix | Cancer therapies | Cisplatin | Developing countries--LDCs | Human papillomavirus | Surgery | Public health
Journal Article
The Journal of Pathology, ISSN 0022-3417, 12/2013, Volume 231, Issue 4, pp. 449 - 456
BRAF and KRAS mutations in ovarian serous borderline tumours (OSBTs) and ovarian low‐grade serous carcinomas (LGSCs) have been previously described. However,... 
mutation | deep sequencing | ovarian low‐grade serous carcinoma | KRAS | BRAF | serous borderline tumour | COLD‐PCR | COLD-PCR | ovarian low-grade serous carcinoma | SURVIVAL | NEOPLASMS | IMPLANTS | PATHOLOGY | PATHOGENESIS | CANCER GENOMICS | ONCOLOGY | RAS MUTATIONS | PROTEIN MUTATIONS | EXPRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | DNA Mutational Analysis - methods | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Adult | Female | Cell Death - drug effects | Tumor Cells, Cultured | High-Throughput Nucleotide Sequencing - methods | MAP Kinase Kinase Kinases - antagonists & inhibitors | Neoplasm Proteins - genetics | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Proto-Oncogene Proteins B-raf - genetics | Benzimidazoles - pharmacology | Neoplasm Recurrence, Local - genetics | Aged | Protein Kinase Inhibitors - pharmacology | DNA, Neoplasm - genetics | Mutation | Cystadenoma, Serous - genetics | Cystadenoma, Serous - pathology | Proteins | Relapse | Carcinoma | Gene mutations | Genomics | Analysis | Denaturation | Cancer | Diseases | KRAS mutation | Ovarian low-grade serous carcinoma | Serous borderline tumor | Deep sequencing | KRAS G12V | BRAF mutation | Full COLD-PCR
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 02/2007, Volume 31, Issue 2, pp. 161 - 169
Journal Article
Histopathology, ISSN 0309-0167, 01/2013, Volume 62, Issue 1, pp. 59 - 70
The histopathological classification of ovarian surface epithelial carcinomas (referred to hereafter as ‘ovarian carcinoma’) has shifted over the past 10 years... 
ovarian carcinoma | clear cell carcinoma | endometrioid carcinoma | serous carcinoma | mucinous carcinoma | molecular pathology | Mucinous carcinoma | Serous carcinoma | Molecular pathology | Clear cell carcinoma | Ovarian carcinoma | Endometrioid carcinoma | GRADE SEROUS CARCINOMA | PHASE-II | STAGE-I | PATHOLOGY | INTRAEPITHELIAL CARCINOMA | CANCER | MUCINOUS TUMORS | CELL BIOLOGY | POOR-PROGNOSIS | EPITHELIAL TUMORS | CLEAR-CELL CARCINOMA | K-RAS PROTOONCOGENE | Adenocarcinoma - pathology | Cystadenocarcinoma, Mucinous - pathology | Humans | Ovarian Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - drug therapy | Ovarian Neoplasms - genetics | Cystadenoma, Serous - drug therapy | Biomarkers, Tumor - metabolism | Female | Adenocarcinoma - genetics | Ovarian Neoplasms - drug therapy | Cystadenocarcinoma, Mucinous - genetics | Carcinoma, Endometrioid - genetics | Carcinoma, Endometrioid - drug therapy | Adenocarcinoma - drug therapy | Cystadenocarcinoma, Mucinous - drug therapy | Adenocarcinoma, Clear Cell - pathology | Mutation | Adenocarcinoma, Clear Cell - genetics | Carcinoma, Endometrioid - pathology | Cystadenoma, Serous - genetics | Adenocarcinoma, Clear Cell - drug therapy | Cystadenoma, Serous - pathology | Chemotherapy | Carcinoma | Health aspects | Ovarian cancer | Cancer | Index Medicus
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 03/2018, Volume 45, Issue 3, pp. 234 - 239
Non‐mammary metastases involving breast are rare and most commonly involve the breast parenchyma. Infrequently, metastasis from an extramammary primary site... 
metastatic ovarian carcinoma | inflammatory carcinoma | serous carcinoma | breast | USEFUL MARKER | OVARIAN-CANCER | GATA3 | PATHOLOGY | P63 | TUMORS | DERMATOLOGY | PAX8 | RECEPTORS | EXPRESSION | UTILITY | CUTANEOUS ADNEXAL NEOPLASMS | Metastasis | Diagnosis | Ovarian cancer | Tumor cells | Dermis | Parenchyma | Breast cancer | Inflammation | Metastases | Literature reviews | Breast carcinoma | GATA-3 protein | Breast | Differential diagnosis | Stains | Peritoneum | Tumors
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2008, Volume 100, Issue 23, pp. 1707 - 1716